Clinical Manifestations of β-Thalassemia Major in Two Different Altitudes; Bushehr and Shahrekord
-
Mohammad Reza Ravanbod
,
Ali Movahed
,
Afshin Ostovar
,
Ali Haji gholami
,
Gholamreza Khamisipour
,
Shokrollah Farrokhi
,
Hossein Darabi
,
Yasaman Khosravi
,
Mohammad Kazzem Gheybi
Abstract
Background: Patients with β-thalassemia major (TM) develop iron overload through increased iron absorption and transfusional therapy and it’s the most important complication of TM. Thalassemia is common in coastal regions and lands with low altitudes. The aim of this study is to determine the effect of high and low altitude on serum ferritin and treatment requirement in two groups of β-thalassemia major (TM) patients.
Subjects and Methods: Patients were divided into two groups, the first group (No: 50) living at sea level (in the port of Bushehr, Iran) and the second group (No: 40) living at the altitude of 2061 m (in the city of Shahrekord, Iran). All patient’s clinical history, blood transfusion and laboratory tests including complete blood count and hemoglobin electrophoresis were reviewed.
Results: There were no significant difference in ferritin levels, transfusion period and diabetes incidence of the two cities patients (P> 0.05). Patient’s cardiac function and liver condition were significantly better in patients of Bushehr (P<0.05). Patients under 20 years in Bushehr were less splenectomized in comparison with Shahrekord (P<0.05).
Conclusion: Our result showed that some of clinical manifestations of patients in low altitude such as cardiac and liver condition were better. But it did not affect ferritin level probably due to transfusion and chelating therapy. Totally patients of Bushehr had better conditions and had longer survivals.
- Abolghasemi H, Amid A, Zeinali S, et al. Thalassemia in Iran: epidemiology, prevention, and management. J Pediatr Hematol Oncol. 2007; 29(4):233-238.
- Flint J, Harding RM, Boyce AJ, et al. The population genetics of the haemoglobinopathies. Baillieres Clin Haematol. 1998; 11(1):1-51.
- Vichinsky EP. Changing patterns of thalassemia worldwide. Ann N Y Acad Sci. 2005; 1054:18-24.
- Cheung YF, Chan GC, Ha SY. Arterial stiffness and endothelial function in patients with beta-thalassemia major. Circulation. 2002 Nov 12; 106(20): 2561-6.
- Jelkmann W. Regulation of erythropoietin production. J Physiol. 2011 Mar 15; 589 (Pt 6): 1251-8.
- Wood JC. Cardiac complications in thalassemia major. Hemoglobin. 2009; 33 (Suppl 1): S 81-86.
- Olivieri NF, Brittenham GM. Iron-chelating therapy and the treatment of thalassemia. Blood. 1997; 89(3):739-761.
- Cunningham MJ, Macklin EA, Neufeld EJ, et al. Complications of beta-thalassemia major in North America. Blood. 2004; 104(1):34-39.
- Cohen AR, Galanello R, Pennell DJ, et al. Thalassemia. Hematology Am Soc Hematol Educ Program. 2004:14-34.
- Hershko C, Link G, Cabantchik I. Pathophysiology of iron overload. Ann N Y Acad Sci. 1998; 850:191-201.
- El-Beshlawy A, Ragab L, Fattah AA, et al. Improvement of cardiac function in thalassemia major treated with L-carnitine. Acta Haematol. 2004; 111(3):143-148.
- Wood JC, Claster S, Carson S, et al. Vitamin D deficiency, cardiac iron and cardiac function in thalassaemia major. Br J Haematol. 2008; 141(6): 891-4.
- Curtain CC, Kidson C, Gajdusek DC, et al. Distribution pattern, population genetics and anthropological significance of thalassemia and abnormal hemoglobins in Melanesia. AM J Phys Anthropol. 1962; 20:475-83.
- Siniscalco M, Bernini L, Filippi G, et al. Population genetics of haemoglobin variants, thalassaemia and glucose-6-phosphate dehydrogenase deficiency, with particular reference to the malaria hypothesis. Bull World Health Organ. 1966; 34(3):379-93.
- Hedrick PW. Population genetics of malaria resistance in humans. Heredity (Edinb). 2011; 107(4):283-304.
- Plato CC, Rucknagel DL, Gershowitz H. Studies on the Distribution of Glucose-6-Phosphate Dehydrogenase Deficiency, Thalassemia, and Other Genetic Traits in the Coastal and Mountain Villages of Cyprus. Am J Hum Genet. 1964; 16:267-83.
- Tzoneva M, Bulanov AG, Mavrudieva M, et al. Frequency of glucose-6-phosphate dehydrogenase deficiency in relation to altitude: a malaria hypothesis. Bull World Health Organ. 1980; 58(4):659-662.
- Claster S, Godwin MJ, Embury SH. Risk of altitude exposure in sickle cell disease. West J Med. 1981; 135(5): 364-7.
- Ganz T. Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation. Blood. 2003; 102(3):783-788.
- Nemeth E, Tuttle MS, Powelson J, et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science. 2004; 306(5704):2090-3.
- Weinstein DA, Roy CN, Fleming MD, et al. Inappropriate expression of hepcidin is associated with iron refractory anemia: implications for the anemia of chronic disease. Blood. 2002; 100(10): 3776-81.
- Piperno A, Galimberti S, Mariani R, et al. Modulation of hepcidin production during hypoxia-induced erythropoiesis in humans in vivo: data from the HIGHCARE project. Blood. 2011; 117(10):2953-9.
- Talbot NP, Lakhal S, Smith TG, et al. Regulation of hepcidin expression at high altitude. Blood. 2012; 119(3):857-60.
- Nemeth E. Hepcidin and beta-thalassemia major. Ann N Y Acad Sci. 2010; 1202:31-5.
- Kirk P, Roughton M, Porter JB, et al. Cardiac T2* magnetic resonance for prediction of cardiac complications in thalassemia major. Circulation. 2009; 120 (20):1961-8.
- Aessopos A, Berdoukas V, Tsironi M. The heart in transfusion dependent homozygous thalassaemia today--prediction, prevention and management. Eur J Haematol. 2008; 80(2):93-106.
- Pepe A, Positano V, Santarelli MF, et al. Multislice multiecho T2* cardiovascular magnetic resonance for detection of the heterogeneous distribution of myocardial iron overload. J Magn Reson Imaging. 2006; 23(5):662-668.
- Galanello R, Origa R. Beta-thalassemia. Orphanet J Rare Dis. 2010; 5:11.
- Bayraktaroglu S, Aydinok Y, Yildiz D, et al. The relationship between the myocardial T2* value and left ventricular volumetric and functional parameters in thalassemia major patients. Diagn Interv Radiol. 2011 Dec; 17(4):346-51.
- Singer DB. Postsplenectomy sepsis. Perspect Pediatr Pathol. 1973.1:285-311.
- Piga A, Serra M, Longo F, et al. Changing patterns of splenectomy in transfusion-dependent thalassemia patients. Am J Hematol. 2011; 86(9):808-810.
- Modell B. Total management of thalassaemia major. Arch Dis Child. 1977; 52(6):489-500.
| Files | ||
| Issue | Vol 10, No 2 (2016) | |
| Section | Articles | |
| Keywords | ||
| β-thalassemia major Ferritin level Cardiac function Altitude | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
